Advagene Biopharma Co., Ltd. (6709.TWO)
- Previous Close
16.20 - Open
15.85 - Bid 15.85 x --
- Ask 16.00 x --
- Day's Range
15.75 - 16.25 - 52 Week Range
15.75 - 30.00 - Volume
116,500 - Avg. Volume
191,615 - Market Cap (intraday)
944.142M - Beta (5Y Monthly) 0.59
- PE Ratio (TTM)
-- - EPS (TTM)
-1.27 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Advagene Biopharma Co., Ltd. engages in the research and development of vaccine technology and related products in Taiwan. Its products in development include nasal spray influenza vaccine, allergy vaccines, and COVID-19 immunotherapy. The company is based in Taipei, Taiwan.
www.advagene.com.twRecent News: 6709.TWO
View MorePerformance Overview: 6709.TWO
Trailing total returns as of 4/22/2025, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 6709.TWO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6709.TWO
View MoreValuation Measures
Market Cap
973.83M
Enterprise Value
778.08M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
4.42
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-23.29%
Return on Equity (ttm)
-38.51%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-69.42M
Diluted EPS (ttm)
-1.27
Balance Sheet and Cash Flow
Total Cash (mrq)
202.32M
Total Debt/Equity (mrq)
2.64%
Levered Free Cash Flow (ttm)
-46.06M